|
Re: Patient Years & MACE rate Question
|
3
|
Resverlogix Corp.
|
Jul 11, 2019 10:23AM
|
|
Re: ESPR results
|
3
|
Resverlogix Corp.
|
Aug 26, 2018 01:52PM
|
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
3
|
Resverlogix Corp.
|
Jan 18, 2022 10:51AM
|
|
Bioequity Europe Monday May 22
|
3
|
Resverlogix Corp.
|
May 18, 2017 11:45AM
|
|
Re: News Release Issued: May 24, 2016 (4:54pm)
|
3
|
Resverlogix Corp.
|
May 24, 2016 08:35PM
|
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
3
|
Resverlogix Corp.
|
Sep 10, 2018 10:40AM
|
|
Re: Novartis & Pfizer withdraw drug application in Europe
|
3
|
Resverlogix Corp.
|
Dec 23, 2018 11:01AM
|
|
Re: flacid
|
3
|
Resverlogix Corp.
|
Jun 09, 2017 10:59AM
|
|
Re: No ESC 2019 Late Breaker
|
3
|
Resverlogix Corp.
|
Jul 02, 2019 12:27PM
|
|
Re: Zenith Capital Corp - Name?
|
3
|
Zenith Epigenetics
|
Aug 15, 2016 12:49PM
|
|
Re: BETonMACE USA vs. non-USA brainstorming
|
3
|
Resverlogix Corp.
|
Nov 21, 2017 10:12AM
|
|
Re: Next Hurdle
|
3
|
Resverlogix Corp.
|
Jan 05, 2018 12:12PM
|
|
Re: Any evidence of success in 2 subgroups
|
3
|
Resverlogix Corp.
|
Mar 30, 2019 10:18PM
|
|
Biogen getting hammered
|
3
|
Resverlogix Corp.
|
Dec 04, 2019 02:46PM
|
|
SAB and data
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2018 09:56AM
|
|
Re: Third Eye and Topline
|
3
|
Resverlogix Corp.
|
Dec 20, 2018 11:57AM
|
|
Re: A fair and optimistic write up on BETonMACE
|
3
|
Resverlogix Corp.
|
Nov 22, 2019 06:03PM
|
|
Re: Reverse Split, the good, bad and in between....
|
3
|
Resverlogix Corp.
|
Aug 15, 2018 08:08AM
|
|
Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
3
|
Resverlogix Corp.
|
Aug 04, 2020 10:38AM
|
|
Re: Note from Sarah Re: Orphan etc.....
|
3
|
Resverlogix Corp.
|
Jun 30, 2015 10:11PM
|
